UNLABELLED: Liver transplantation (LT) is a unique model to study hepatitis C virus (HCV) entry into hepatocytes. Recent in vitro studies suggest significant changes in the expression of the HCV receptors claudin-1 and occludin after HCV infection. Our aims were: (1) to characterize claudin-1 and occludin expression in grafts from LT recipients and (2) to explore their potential influence on early HCV kinetics and their changes after HCV infection. We included 42 HCV-infected LT recipients and 19 uninfected controls. Claudin-1 and occludin were detected in paraffin-embedded liver biopsies obtained during reperfusion and 3 and 12 months after LT. HCV receptors were characterized by confocal immunofluorescence microscopy; quantification and colocalization studies were performed with dedicated software. Claudin-1 and occludin expression were restricted to the apical pole of hepatocytes. There was a significant correlation between the amount of scavenger receptor B1 at the time of reperfusion and the HCV-RNA decay during the first 24 hours following LT (r = 0.55, P = 0.007). Similarly, there was a significant correlation between the levels of claudin and occludin and the slope of HCV-RNA increase during the first week after LT (r = 0.63, P = 0.005). Occludin and claudin-1 levels increased significantly 12 months after LT (P = 0.03 and P = 0.007, respectively). The expression pattern of both proteins, however, remained unchanged, colocalizing strongly (60%-94%) at the apical membrane of hepatocytes. CONCLUSIONS: HCV receptor levels at the time of LT seem to modulate early HCV kinetics. Hepatitis C recurrence after LT was associated with increased levels of claudin-1 and occludin in the hepatocyte cell membrane, although it did not alter their localization within the tight junctions.
UNLABELLED: Liver transplantation (LT) is a unique model to study hepatitis C virus (HCV) entry into hepatocytes. Recent in vitro studies suggest significant changes in the expression of the HCV receptors claudin-1 and occludin after HCV infection. Our aims were: (1) to characterize claudin-1 and occludin expression in grafts from LT recipients and (2) to explore their potential influence on early HCV kinetics and their changes after HCV infection. We included 42 HCV-infected LT recipients and 19 uninfected controls. Claudin-1 and occludin were detected in paraffin-embedded liver biopsies obtained during reperfusion and 3 and 12 months after LT. HCV receptors were characterized by confocal immunofluorescence microscopy; quantification and colocalization studies were performed with dedicated software. Claudin-1 and occludin expression were restricted to the apical pole of hepatocytes. There was a significant correlation between the amount of scavenger receptor B1 at the time of reperfusion and the HCV-RNA decay during the first 24 hours following LT (r = 0.55, P = 0.007). Similarly, there was a significant correlation between the levels of claudin and occludin and the slope of HCV-RNA increase during the first week after LT (r = 0.63, P = 0.005). Occludin and claudin-1 levels increased significantly 12 months after LT (P = 0.03 and P = 0.007, respectively). The expression pattern of both proteins, however, remained unchanged, colocalizing strongly (60%-94%) at the apical membrane of hepatocytes. CONCLUSIONS:HCV receptor levels at the time of LT seem to modulate early HCV kinetics. Hepatitis C recurrence after LT was associated with increased levels of claudin-1 and occludin in the hepatocyte cell membrane, although it did not alter their localization within the tight junctions.
Authors: Mirjam B Zeisel; George Koutsoudakis; Eva K Schnober; Anita Haberstroh; Hubert E Blum; François-Loïc Cosset; Takaji Wakita; Daniel Jaeck; Michel Doffoel; Cathy Royer; Eric Soulier; Evelyne Schvoerer; Catherine Schuster; Françoise Stoll-Keller; Ralf Bartenschlager; Thomas Pietschmann; Heidi Barth; Thomas F Baumert Journal: Hepatology Date: 2007-12 Impact factor: 17.425
Authors: Jennifer M Timpe; Zania Stamataki; Adam Jennings; Ke Hu; Michelle J Farquhar; Helen J Harris; Anne Schwarz; Isabelle Desombere; Geert Leroux Roels; Peter Balfe; Jane A McKeating Journal: Hepatology Date: 2008-01 Impact factor: 17.425
Authors: Alexander Ploss; Matthew J Evans; Valeriya A Gaysinskaya; Maryline Panis; Hana You; Ype P de Jong; Charles M Rice Journal: Nature Date: 2009-01-28 Impact factor: 49.962
Authors: Philip Meuleman; Maria Teresa Catanese; Lieven Verhoye; Isabelle Desombere; Ali Farhoudi; Christopher T Jones; Timothy Sheahan; Katarzyna Grzyb; Riccardo Cortese; Charles M Rice; Geert Leroux-Roels; Alfredo Nicosia Journal: Hepatology Date: 2011-12-16 Impact factor: 17.425
Authors: Koen Vercauteren; Naomi Van Den Eede; Ahmed Atef Mesalam; Sandrine Belouzard; Maria Teresa Catanese; Dorothea Bankwitz; Flossie Wong-Staal; Riccardo Cortese; Jean Dubuisson; Charles M Rice; Thomas Pietschmann; Geert Leroux-Roels; Alfredo Nicosia; Philip Meuleman Journal: Hepatology Date: 2014-07-30 Impact factor: 17.425
Authors: Maria Teresa Catanese; Joana Loureiro; Christopher T Jones; Marcus Dorner; Thomas von Hahn; Charles M Rice Journal: J Virol Date: 2013-05-22 Impact factor: 5.103
Authors: Ágnes Holczbauer; Benedek Gyöngyösi; Gábor Lotz; Péter Törzsök; Pál Kaposi-Novák; Attila Szijártó; Péter Tátrai; Péter Kupcsulik; Zsuzsa Schaff; András Kiss Journal: Pathol Oncol Res Date: 2014-04-03 Impact factor: 3.201
Authors: Marta Melis; Giacomo Diaz; David E Kleiner; Fausto Zamboni; Juraj Kabat; Jinping Lai; Giulia Mogavero; Ashley Tice; Ronald E Engle; Steven Becker; Charles R Brown; Jeffrey C Hanson; Jaime Rodriguez-Canales; Michael Emmert-Buck; Sugantha Govindarajan; Michael Kew; Patrizia Farci Journal: J Transl Med Date: 2014-08-21 Impact factor: 5.531